Drugs
Title
Date Published
Effect of tranexamic acid on postoperative bleeding in pediatric heart surgery
March 1, 2007
Recombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndrome.
March 1, 2007
Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery.
February 7, 2007
A Variant of Recombinant Factor VIIa With Enhanced Procoagulant and Antifibrinolytic Activities in an In Vitro Model of Hemophilia.
January 4, 2007
Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis.
January 1, 2007
Effects of tranexamic Acid and autotransfusion in coronary artery bypass.
January 1, 2007
Ultra-low dose aprotinin effects on reducing the need for blood transfusion in cardiac surgery.
January 1, 2007
Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
December 21, 2006
Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding. A European perspective.
December 12, 2006
Aprotinin; friend or foe? A review of recent medical literature.
November 14, 2006
Do Antifibrinolytics Reduce Allogeneic Blood Transfusion in Orthopedic Surgery?
November 3, 2006
Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia.
October 15, 2006
Rescue Treatment With Recombinant Factor VIIa is Effective in Patients With Life-threatening Bleedings Secondary to Major Wound Excision: A Report of Four Cases.
October 1, 2006
Thrombogenic side-effects of recombinant factor VIIa after use in coronary artery bypass surgery.
October 1, 2006
Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation.
September 1, 2006
Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.
September 1, 2006
The Use of Antifibrinolytic Agents in Total Hip Arthroplasty A Meta-analysis.
September 1, 2006
Recombinant factor VIIa and the surgical patient.
August 1, 2006
Determinants of complications with recombinant factor VIIa for refractory blood loss in cardiac surgery.
August 1, 2006
The Clinical and Laboratory Response to Recombinant Factor VIIa in Trauma and Surgical Patients with Acquired Coagulopathy.
July 31, 2006